[1]
Castaman, G. 2016. [Cost-minimization analysis of replacement therapy in the treatment of von Willebrand disease]. Farmeconomia. Health economics and therapeutic pathways. 17, 2 (Jun. 2016), 59–65. DOI:https://doi.org/10.7175/fe.v17i2.1249.